Kao (4452) FY2026 Q2 Earnings Report

Quick View

Executive Summary

Profit growth substantially outpaced revenue growth, making improved profitability the most important feature of the current period’s results. Revenue was ¥871.93B (+7.8% year on year), Operating Income was ¥95.83B (+38.5%), Profit Before Tax, corresponding to the ordinary income stage, was ¥97.32B (+35.6%), and Net Income attributable to owners of the parent was ¥65.66B (+32.3%). The Operating Margin improved to 11.0%, approximately 2.4pt above approximately 8.6% in the same period of the previous year, with operating leverage from improved gross margins and greater cost efficiency driving profit growth.

Factors Affecting Performance

【Revenue】All segments posted revenue growth, led by GlobalConsumerCare, which generated Revenue of ¥649.49B (+7.2%) and accounted for approximately 74% of total revenue. Cosmetics and Chemical recorded relatively high growth of +10.5% and +9.5%, respectively, while HygieneLivingCare was limited to +5.0%. Total company Revenue was ¥871.93B (+7.8%), indicating a generally well-balanced contribution to growth across segments.

【Profit and Loss】Operating Income was ¥95.83B (+38.5%), substantially exceeding the revenue growth rate, and the Operating Margin expanded to 11.0%. In particular, Cosmetics’ Operating Income increased significantly to ¥5.76B (+1603.6% year on year), with the recovery in profitability lifting the overall profit growth rate. HygieneLivingCare maintained the highest margin among all segments at 14.5% and remained a core contributor to earnings. Profit Before Tax of ¥97.32B slightly exceeded Operating Income, with equity-method income of ¥1.63B making a positive contribution. The key feature of the current period was that profit growth substantially exceeded revenue growth.

Segment Analysis

GlobalConsumerCare recorded Revenue of ¥649.49B (+7.2%) and Operating Income of ¥65.71B (+20.4%), with its margin improving from the previous year to 10.1%. HygieneLivingCare generated Revenue of ¥270.72B (+5.0%) and Operating Income of ¥39.17B (+10.1%), achieving the highest margin among all segments at 14.5% and serving as a core earnings pillar. Cosmetics posted Revenue of ¥130.98B (+10.5%) and Operating Income of ¥5.76B, a sharp expansion from the previous year; however, its margin of 4.4% remained below that of the other segments. Chemical recorded Revenue of ¥222.44B (+9.5%) and Operating Income of ¥18.07B (+26.2%), delivering both revenue and profit growth and improving its margin to 8.1%. HealthBeautyCare recorded Revenue of ¥228.64B (+8.1%) and Operating Income of ¥19.94B (+9.3%), with profit growth remaining broadly in line with revenue growth. BusinessConnected was small in scale but achieved substantial profit growth, with Operating Income of ¥0.84B (+101.2%). Overall, the recovery in Cosmetics’ profitability was one of the primary drivers of consolidated profit growth.

Key Financial Indicators

【Profitability】The Operating Margin of 11.0% improved by approximately 2.4pt year on year, while the Net Margin also increased to approximately 7.5%. The Gross Margin was 39.8% compared with an SG&A ratio of 30.3%; the improvement in gross profit exceeded the increase in SG&A expenses and was converted into Operating Income.【Cash Flow Quality】Operating Cash Flow (OCF) was ¥55.25B, representing a ratio of 0.84x to Net Income of ¥66.23B, indicating that cash did not increase to the same extent as earnings. The primary factor was a ¥20.76B increase in inventories.【Investment Efficiency】ROE was 5.8%, while total asset turnover remained low; the substantial equity base (Equity Ratio of 59.0%) relatively constrained capital efficiency. EPS was ¥72.58 (¥53.42 in the previous year, +35.9%), and BPS was ¥1,237.29.【Financial Soundness】The Equity Ratio was 59.0%, cash and deposits were ¥326.66B, and interest-bearing debt (total bonds and borrowings) was ¥132.31B, indicating a stable financial foundation. Goodwill of ¥235.56B was equivalent to 20.5% of net assets and was not excessive in absolute terms.

Cash Flow Analysis

Operating Cash Flow was ¥55.25B, up +28.9% year on year, but its ratio to Net Income of ¥66.23B remained at 0.84x, indicating somewhat weak cash conversion. From the OCF subtotal of ¥89.54B, the ¥20.76B increase in inventories, other factors reducing working capital, and corporate income taxes paid of ¥34.29B were deducted to arrive at final OCF. Investing Cash Flow was an outflow of ¥12.03B; although capital expenditures of ¥28.65B continued, part of the outflow was offset by the withdrawal of time deposits and other factors. Financing Cash Flow was an outflow of ¥48.64B, primarily due to dividend payments of ¥34.87B, while share repurchases were minor at ¥0.01B. Free Cash Flow, calculated as OCF plus Investing Cash Flow, was ¥43.22B; since this was below dividend payments, the current period’s dividends involved capital allocation using cash on hand (cash and cash equivalents of ¥326.66B) and retained earnings.

Quality of Earnings

The current period’s profit growth was primarily attributable to improved profitability at the operating level, with limited contribution from temporary factors resembling extraordinary gains and losses. Profit Before Tax of ¥97.32B was only slightly above Operating Income of ¥95.83B. Non-operating income and expenses, consisting of financial income of ¥0.01B and financial expenses of ¥2.87B, were broadly neutral, while equity-method income of ¥1.63B made a modest positive contribution. Accordingly, recurring business earnings accounted for the majority of profit. On the other hand, OCF below Net Income suggests the presence of accruals—the divergence between accrual-based earnings and cash flows—with the increase in inventories being the primary factor. Total comprehensive income of ¥90.61B exceeded Net Income of ¥66.23B, and other comprehensive income, centered on foreign currency translation adjustments, made a positive contribution; however, this should be distinguished from the recurring earning power of the business.

Earnings Forecast and Guidance

The full-year company forecast calls for Revenue of ¥1,800.00B (+6.6%), Operating Income of ¥190.00B (+16.2%), and forecast EPS of ¥149.21, with the earnings forecast revised during the current quarter. Based on first-half results, progress rates were 48.4% for Revenue and 50.4% for Operating Income, both remaining close to the standard half-year progress level of 50%. Although the first-half Operating Income growth rate of 38.5% substantially exceeded the full-year forecast growth rate of 16.2%, the progress rate itself was not exceptional, consistent with a plan for profit growth to moderate in the second half compared with the first half. In the second half, inventory normalization and maintaining an Operating Margin of 11.0% will be key points of focus for achieving the full-year forecast.

Shareholder Returns

The dividend at the end of Q2 was ¥78.00 per share. The Payout Ratio calculated based on Net Income for the interim period was above 100%, while share repurchases were minor at ¥0.01B; therefore, shareholder returns for the current period were centered on dividends. Dividend payments of ¥34.87B were below Free Cash Flow of ¥43.22B and therefore remained within the range of Free Cash Flow, although the full-year Payout Ratio may reach a high level. In addition, a 1-for-2 stock split is scheduled for July 2026, and the company’s forecast annual dividend before reflecting the stock split is ¥156.00 per share. No revision was made to the dividend forecast.

Risk Factors

1. Inventory accumulation risk: Inventories were ¥317.47B, an increase of ¥20.76B from the previous year. The increase in inventories is weighing on OCF, and if a mismatch with demand trends persists, it could lead to risks of impairment losses or discount sales.

2. Relative weakness in cash generation: OCF of ¥55.25B was only 0.84x Net Income of ¥66.23B. Changes in working capital are limiting the conversion of earnings into cash, and if this situation continues, funding for dividends and capital expenditures will become increasingly dependent on cash on hand.

3. Capital efficiency challenges: ROE of 5.8% remains relatively low despite a substantial capital base, reflected in an Equity Ratio of 59.0%. Low total asset turnover is a contributing factor, leaving room for improvement in asset efficiency.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Profitability exceeded the industry median for both Operating Margin and Net Margin, placing the company in a relatively favorable position within the industry.

Growth and Capital Efficiency

The Revenue Growth Rate was slightly below the industry median, with improved profitability offsetting the company’s relative disadvantage in growth.

※Source: Compiled by the Company

Key Points from the Earnings Results

1. Revenue increased +7.8%, while Operating Income increased +38.5%, improving the Operating Margin to 11.0%. The recovery in profitability in the Cosmetics segment made a significant contribution to overall profit growth.

2. OCF fell below Net Income (ratio of 0.84x), with the increase in inventories being the primary factor. This gap between earnings growth and cash generation requires ongoing monitoring.

3. Progress toward the full-year forecast was 48.4% for Revenue and 50.4% for Operating Income, both standard levels; the high first-half profit growth rate does not in itself indicate upside to the full-year forecast.

Theoretical Share Price (Reference Value)

Sensitivity: ¥1,353–¥1,434 at ±1% for the Cost of Equity, and ¥1,389–¥1,398 at ±0.1 for ω.

Notes:

• Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).

(Calculation model: Residual Income Model (Ohlson type; explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated values based solely on publicly disclosed data; these are not forecasts of market prices or recommendations for specific investment actions and do not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

Kao delivered a strong FY2026 Q2 earnings recovery, with revenue growth translating into substantially faster operating and attributable-profit growth. Revenue increased 7.8% year on year to ¥871.9bn. Operating income rose 38.5% to ¥95.8bn. Profit attributable to owners increased 32.3% to ¥65.7bn. The operating margin expanded to 11.0% from 8.6% in the prior-year period, a gain of approximately 245 basis points. Gross margin improved to 39.8% from approximately 38.5%, representing about 128 basis points of expansion. This indicates that the margin recovery was led primarily by gross-profit improvement rather than sales growth alone. SG&A increased 8.5% to ¥264.0bn, slightly exceeding revenue growth, and the SG&A-to-sales ratio increased by about 20 basis points to 30.3%. Nevertheless, gross-margin expansion more than offset this cost increase and generated meaningful operating leverage. Profit before tax rose 35.6% to ¥97.3bn, broadly tracking operating-income growth. The effective tax rate was 31.9%, resulting in a tax burden of 0.675x, modestly below the 0.70x normal benchmark. Net profit margin was 7.5%, placing profitability within the good 5-10% range but below the 10% level generally associated with excellent consumer-goods profitability. Operating cash flow increased to ¥55.3bn, but cash conversion remained less than full because operating cash flow was only 0.84x attributable profit. Inventory investment absorbed ¥20.8bn of cash and inventory days of 110 are elevated, making inventory normalization a key determinant of second-half cash generation. Free cash flow was ¥43.2bn on the supplied definition, aided by ¥14.3bn of proceeds from sales of property, plant and equipment. Management revised its FY2026 forecast, and Q2 operating-income progress is marginally ahead of the normal halfway point. The full-year outlook therefore appears attainable on the reported run rate, but sustaining the upgraded earnings trajectory will require continued gross-margin discipline, controlled SG&A growth, and avoidance of further inventory accumulation.

Profitability Analysis

Annualized DuPont ROE is 11.4%, comprising a 7.5% net profit margin, 0.919x asset turnover, and 1.65x financial leverage. The largest positive earnings change was margin expansion: operating margin increased by approximately 245 basis points year on year, whereas sales increased 7.8%. Gross margin improved by approximately 128 basis points to 39.8%, demonstrating improved conversion of revenue into gross profit. The remaining operating-margin improvement reflects favorable operating leverage, although SG&A grew 8.5%, or modestly faster than revenue, and therefore did not contribute to cost-ratio improvement. At 1.65x, financial leverage is moderate and is not the primary driver of the 11.4% annualized ROE. Asset turnover of 0.919x is reasonable for a global branded consumer-products manufacturer with sizable manufacturing assets and intangible assets, but the 110-day inventory position constrains working-capital efficiency. The extended DuPont tax burden of 0.675x reflects a 31.9% effective tax rate and modestly suppresses conversion from pretax income to net income. The interest burden is 1.016x because finance income and equity-method contribution more than offset finance costs at the pretax-profit level; finance costs of ¥2.9bn are small relative to EBIT of ¥95.8bn. Equity-method investment income was ¥1.6bn, equivalent to only about 1.7% of operating income, so earnings remain predominantly driven by consolidated operations. The profitability improvement appears operationally meaningful given simultaneous revenue and gross-profit growth, but the pace of SG&A growth should be monitored to determine whether margin expansion can be sustained.

Growth Assessment

Revenue growth of 7.8% to ¥871.9bn supports a broad improvement in the earnings base rather than a purely cost-driven profit outcome. Operating income growth of 38.5% materially exceeded sales growth, reflecting strong incremental profitability. At Q2, revenue represents 48.4% of the ¥1,800.0bn full-year forecast, only 1.6 percentage points below the standard 50% midyear progress rate. Operating income represents 50.4% of the ¥190.0bn forecast, 0.4 percentage points ahead of the standard midyear rate. Attributable profit represents 48.6% of the ¥135.0bn forecast, 1.4 percentage points below the standard midyear rate. These deviations are well within the 10-percentage-point threshold and indicate that the revised annual plan is broadly consistent with the first-half result. The FY2026 forecast implies 6.6% revenue growth, 16.2% operating-income growth, and 12.4% net-income growth for the full year. Since first-half operating-income growth is substantially above the full-year growth assumption, the plan embeds more moderate second-half margin progression. Gross-margin improvement is the central positive driver of earnings quality. However, SG&A growth slightly above revenue growth means that future margin improvement cannot rely on expense leverage alone. Inventory rose ¥251.1bn year on year to ¥317.5bn and the supplied 110 inventory days signal elevated stock intensity. For a household and personal-care manufacturer, prolonged inventory levels can raise promotion, obsolescence, and working-capital risks even where branded-product demand is resilient. The forecast revision is supportive of the operating trajectory, while the required second-half focus is conversion of inventory into sales and cash.

Financial Health

Financial health is solid, supported by total equity of ¥1,149.5bn, an equity ratio of 59.0%, and total liabilities equal to 39.4% of assets. Current assets of ¥938.6bn compared with estimated current liabilities of ¥520.0bn imply a current ratio of approximately 1.80x, comfortably above the 1.0x warning level and the 1.5x healthy benchmark. Cash and cash equivalents totaled ¥326.7bn. Current borrowings were ¥51.7bn and current lease liabilities were ¥20.4bn, together well covered by cash and current assets. Total interest-bearing borrowings were approximately ¥132.3bn, consisting of ¥51.7bn current and ¥80.6bn non-current borrowings. Lease liabilities totaled ¥104.9bn, with ¥84.5bn non-current. The reported debt-to-equity ratio of 0.65x remains far below the 2.0x aggressive-financing warning level. The capital structure therefore does not indicate a liquidity shortfall or an acute maturity mismatch. Compared with the prior-year period, current borrowings increased by ¥25.7bn while non-current borrowings declined by ¥25.0bn, indicating a refinancing or maturity reclassification shift rather than a material increase in total borrowings. Accounts payable of ¥272.7bn and contract liabilities of ¥42.8bn provide operating funding, though they should be assessed alongside elevated inventory. Goodwill of ¥235.6bn equals 20.5% of equity and 12.4% of assets, below the applicable 30% and 50% caution thresholds. Intangible assets equal 4.1% of total assets, indicating no excessive concentration in acquired intangible assets. Right-of-use assets of ¥106.3bn are substantially matched by lease liabilities and should be treated as a continuing fixed-payment commitment within the capital structure.

Notable B/S Changes

Inventories: +¥251.1bn year on year to ¥317.5bn - a material increase that is consistent with the 110-day inventory alert and the ¥20.8bn inventory-related operating-cash-flow outflow; sell-through and inventory quality require close monitoring. Equity attributable to owners: +¥555.7bn year on year to ¥1,119.4bn - higher retained earnings and positive translation-related OCI strengthened capital capacity and lifted the equity ratio to 59.0% from 56.7%. Retained earnings: +¥309.1bn year on year to ¥747.5bn - supports balance-sheet resilience and dividend capacity, although the payout ratio remains above 100%. Non-current liabilities: -¥333.9bn year on year to ¥228.8bn - principally accompanied by a shift in borrowings, with non-current borrowings declining ¥250.3bn and current borrowings increasing ¥256.8bn; overall liquidity remains ample. Property, plant and equipment: -¥74.8bn year on year to ¥435.6bn - stable capital expenditure of ¥28.6bn was more than offset by depreciation, disposals, and other movements, warranting monitoring for maintenance of manufacturing capacity.

Cash Flow Quality

Operating cash flow was ¥55.3bn, up from ¥42.9bn in the prior-year period, but it represented only 0.84x attributable profit of ¥65.7bn. This is above the 0.8x concern threshold but below the 1.0x high-quality cash-conversion benchmark, indicating adequate rather than strong first-half earnings conversion. The low accruals ratio of 0.6% is favorable and does not suggest broad accrual-based earnings inflation. Inventory growth was a principal cash drag, absorbing ¥20.8bn in operating cash flow. Other working-capital changes absorbed a further ¥31.5bn. Receivables released ¥6.3bn of cash and payables contributed ¥7.8bn, providing partial offsets. The supplied quality alert of 110 inventory days is material because it exceeds both the 90-day warning threshold and the 60-day manufacturing efficiency benchmark. The root cause indicated by the cash-flow statement is inventory accumulation, which ties up cash despite the strong reported profit growth. For a consumer-products manufacturer, elevated stock can reflect safety-stock policies, production phasing, slower sell-through, or a mismatch between supply and demand; irrespective of cause, it increases the risk of promotional pressure or inventory write-downs if it persists. The impact is that earnings growth currently converts into cash less efficiently than would be expected from a mature branded consumer franchise. Free cash flow was ¥43.2bn under the supplied definition, after investing cash flow of ¥12.0bn. This result includes ¥14.3bn of proceeds from sales of PPE, while cash capital expenditure was ¥28.6bn and intangible purchases were ¥3.5bn. Excluding the asset-sale proceeds, recurring operating cash flow less cash capital expenditure would be approximately ¥26.6bn, underscoring the importance of inventory and working-capital normalization for recurring free-cash-flow expansion. Capex was broadly stable year on year, suggesting that the first-half cash-conversion issue is principally working-capital-related rather than a surge in investment spending.

Dividend Sustainability

The interim dividend is ¥78.00 per share on the pre-split basis. The company executed a two-for-one stock split effective July 1, 2026; on a non-split-adjusted basis, management forecasts a ¥78.00 year-end dividend and ¥156.00 annual dividend for FY2026. The supplied calculated payout ratio is 107.8%, above the 100% warning threshold. Using the full-year EPS forecast of ¥149.21 and the non-split-adjusted annual dividend of ¥156.00 also implies a prospective payout ratio of approximately 104.6%. Accordingly, the dividend policy is supported by balance-sheet capacity and retained earnings but is not fully covered by forecast earnings on a conventional payout-ratio basis. The supplied free-cash-flow coverage is 0.61x, also signaling that internally generated free cash flow does not fully cover the indicated dividend commitment. Cash dividends paid in the first half were ¥34.9bn, compared with supplied free cash flow of ¥43.2bn; however, the latter benefited from PPE disposal proceeds and remains affected by working-capital outflows. Retained earnings of ¥747.5bn and cash of ¥326.7bn provide substantial near-term funding flexibility. Treasury-share purchases were immaterial at ¥0.01bn, so the shareholder-return assessment is overwhelmingly a dividend issue rather than a buyback-driven total-return issue. Dividend sustainability would improve materially if the company converts elevated inventory into cash and sustains the improved operating margin. In contrast, a prolonged inventory build or a reversal in gross-margin gains would increase the reliance on cash reserves or balance-sheet capacity to maintain the dividend.

Risk Assessment

Business risks include Inventory and sell-through risk: the supplied 110 days of inventory exceeds both 90-day and 60-day warning benchmarks. Further inventory accumulation could require promotional activity, increase obsolescence exposure, and dilute gross-margin gains., Input-cost, packaging, energy, and logistics inflation risk: the Q2 gross-margin recovery is a key earnings driver, making profitability sensitive to any renewed cost inflation that cannot be recovered through pricing or mix., Competitive consumer-products risk: maintaining the 11.0% operating margin requires brand investment and innovation, while SG&A grew 8.5%, faster than revenue growth of 7.8%., Foreign-exchange and overseas-operation risk: translation differences contributed ¥225.9bn to other comprehensive income, demonstrating that foreign-currency movements remain material to reported equity and comprehensive income., Product-quality, regulatory, and environmental risk: as a global household, personal-care, and chemical-related manufacturer, Kao remains exposed to product-safety requirements, chemical regulation, and reputational consequences of quality incidents..

Financial risks include Cash-conversion risk: operating cash flow was 0.84x attributable profit, below the 1.0x high-quality benchmark, principally due to inventory and other working-capital cash absorption., Dividend-coverage risk: the supplied payout ratio of 107.8% and FCF coverage of 0.61x indicate dividend commitments exceed both reported earnings and supplied free cash flow on the stated measures., Refinancing-structure risk: ¥51.7bn of borrowings are current, following a shift from non-current to current borrowings. Liquidity is strong, but the maturity profile should be monitored., Goodwill retention risk: goodwill of ¥235.6bn is currently moderate at 20.5% of equity, but its value remains dependent on acquired businesses meeting their operating assumptions..

Key concerns include Highest priority: inventory days of 110 and the related ¥20.8bn operating-cash-flow outflow, because this directly affects cash conversion, margin risk, and dividend funding., High priority: whether gross-margin expansion can be maintained while SG&A continues to grow faster than sales., Medium priority: a dividend payout above 100%, which is manageable given the strong balance sheet but depends on continued earnings and cash-flow improvement., Medium priority: translation-driven equity volatility, despite no immediate balance-sheet stress..

Investment Implications

Key takeaways include Q2 showed a strong operational recovery: operating income increased 38.5% and operating margin improved approximately 245 basis points to 11.0%., The annualized 11.4% ROE is in the good range and is driven primarily by improved profitability rather than increased leverage., The revised FY2026 forecast is broadly on track, with Q2 progress of 48.4% for revenue, 50.4% for operating income, and 48.6% for attributable profit., Inventory efficiency is the principal counterweight to the earnings recovery, given 110 inventory days and a ¥20.8bn inventory-related operating-cash-flow outflow., The balance sheet is robust, but dividend coverage is tight on both the supplied 107.8% payout ratio and 0.61x FCF-coverage measure..

Metrics to watch include Gross margin and operating margin progression versus the Q2 levels of 39.8% and 11.0%, respectively, SG&A growth relative to revenue growth, Inventory days and absolute inventories, currently 110 days and ¥317.5bn, Operating cash flow relative to attributable profit, currently 0.84x, Second-half conversion of the ¥190.0bn full-year operating-income forecast, Dividend payout ratio and free-cash-flow coverage, Current versus non-current borrowing mix following the FY2026 Q2 maturity shift.

Regarding relative positioning, Kao presents the financial profile of a well-capitalized global consumer-products manufacturer: healthy liquidity, moderate leverage, a 59.0% equity ratio, and operating margins in the good benchmark range. The Q2 margin recovery and annualized 11.4% ROE strengthen its relative profitability profile, while elevated inventory days and above-100% dividend payout distinguish its cash-flow and shareholder-distribution profile as areas requiring closer scrutiny.